Klaviyo, Inc. (NYSE:KVYO – Get Free Report) President Stephen Eric Rowland sold 4,536 shares of Klaviyo stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $34.56, for a total value of $156,764.16. Following the transaction, the president now directly owns 186,785 shares of the company’s stock, valued at $6,455,289.60. The trade was a 2.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Stephen Eric Rowland also recently made the following trade(s):
- On Tuesday, October 15th, Stephen Eric Rowland sold 18,114 shares of Klaviyo stock. The stock was sold at an average price of $37.19, for a total transaction of $673,659.66.
- On Monday, September 16th, Stephen Eric Rowland sold 18,114 shares of Klaviyo stock. The stock was sold at an average price of $31.24, for a total value of $565,881.36.
Klaviyo Stock Up 1.6 %
NYSE:KVYO opened at $35.01 on Thursday. The firm’s fifty day simple moving average is $36.04 and its 200 day simple moving average is $29.42. The stock has a market cap of $9.44 billion, a P/E ratio of -194.50 and a beta of 1.13. Klaviyo, Inc. has a twelve month low of $21.26 and a twelve month high of $41.00.
Hedge Funds Weigh In On Klaviyo
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Advisors Asset Management Inc. boosted its stake in Klaviyo by 145.6% during the third quarter. Advisors Asset Management Inc. now owns 1,363 shares of the company’s stock worth $48,000 after acquiring an additional 808 shares in the last quarter. nVerses Capital LLC purchased a new position in shares of Klaviyo in the 3rd quarter worth about $53,000. EntryPoint Capital LLC purchased a new stake in Klaviyo during the 1st quarter valued at about $71,000. Dark Forest Capital Management LP grew its position in Klaviyo by 13.7% during the 2nd quarter. Dark Forest Capital Management LP now owns 23,689 shares of the company’s stock valued at $590,000 after purchasing an additional 2,851 shares during the last quarter. Finally, West Tower Group LLC purchased a new position in Klaviyo in the third quarter worth about $177,000. Hedge funds and other institutional investors own 45.43% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Wells Fargo & Company reiterated a “buy” rating on shares of Klaviyo in a research report on Friday, October 18th. Piper Sandler upped their price objective on Klaviyo from $34.00 to $45.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. Robert W. Baird lifted their price target on shares of Klaviyo from $42.00 to $45.00 and gave the stock an “outperform” rating in a research note on Thursday, November 7th. Barclays upped their price objective on shares of Klaviyo from $32.00 to $41.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Cantor Fitzgerald raised their price objective on Klaviyo from $33.00 to $47.00 and gave the company an “overweight” rating in a research note on Thursday, November 7th. Three analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $39.00.
Read Our Latest Analysis on Klaviyo
Klaviyo Company Profile
Klaviyo, Inc, a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure.
Further Reading
- Five stocks we like better than Klaviyo
- Following Congress Stock Trades
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How to Invest in Biotech Stocks
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Klaviyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klaviyo and related companies with MarketBeat.com's FREE daily email newsletter.